Hofer & Associates’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Hofer & Associates's AMGN Position: Q3 2026 in Review
Hofer & Associates reduced its Amgen (AMGN) stake by 94% in Q3 2026, selling an estimated $10.3M and leaving 1,567 shares worth $661K. The position accounts for 0.46% of the portfolio, ranked #50.
Hofer & Associates first reported a position in AMGN in Q4 2021 and has held it in 20 quarters since. The position peaked at $10M in Q2 2026. 965 funds tracked by Wall St. Rank hold AMGN as of Q3 2026.
- Hofer & Associates held 1,567 shares of Amgen worth $661K as of Q3 2026.
- Hofer & Associates sold 25,913 Amgen shares in Q3 2026, an estimated $10.3M.
- Amgen made up 0.46% of Hofer & Associates's portfolio in Q3 2026, its #50 holding.
- Hofer & Associates first reported a position in Amgen in Q4 2021 and has held it in 20 quarters since.
- Hofer & Associates's Amgen position peaked at $10M in Q2 2026.
- 965 funds tracked by Wall St. Rank held Amgen as of Q3 2026.
Based on Hofer & Associates's 13F filing for Q3 2026, filed 13 Oct 2026.